Your browser doesn't support javascript.
loading
Monocyte-derived macrophages aggravate pulmonary vasculitis via cGAS/STING/IFN-mediated nucleic acid sensing.
Kessler, Nina; Viehmann, Susanne F; Krollmann, Calvin; Mai, Karola; Kirschner, Katharina M; Luksch, Hella; Kotagiri, Prasanti; Böhner, Alexander M C; Huugen, Dennis; de Oliveira Mann, Carina C; Otten, Simon; Weiss, Stefanie A I; Zillinger, Thomas; Dobrikova, Kristiyana; Jenne, Dieter E; Behrendt, Rayk; Ablasser, Andrea; Bartok, Eva; Hartmann, Gunther; Hopfner, Karl-Peter; Lyons, Paul A; Boor, Peter; Rösen-Wolff, Angela; Teichmann, Lino L; Heeringa, Peter; Kurts, Christian; Garbi, Natalio.
Afiliação
  • Kessler N; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Viehmann SF; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Krollmann C; Medical Clinic and Polyclinic III, University Hospital Bonn, Bonn, Germany.
  • Mai K; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Kirschner KM; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Luksch H; Department of Pediatrics, Universitätsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany.
  • Kotagiri P; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Böhner AMC; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Huugen D; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
  • de Oliveira Mann CC; Department of Internal Medicine, Division of Clinical and Experimental Immunology, University of Maastricht, Maastricht, Netherlands.
  • Otten S; Gene Center, Ludwig Maximilians University, Munich, Germany.
  • Weiss SAI; Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Zillinger T; Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München and University Hospital of the Ludwig-Maximilians University, Munich, Germany.
  • Dobrikova K; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Jenne DE; Institute of Molecular Medicine and Experimental Immunology, Medical Faculty, University of Bonn, Bonn, Germany.
  • Behrendt R; Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München and University Hospital of the Ludwig-Maximilians University, Munich, Germany.
  • Ablasser A; Max Planck Institute of Neurobiology, Planegg-Martinsried, Planegg, Germany.
  • Bartok E; Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Hartmann G; Global Health Institute, Swiss Federal Institute of Technology, Lausanne, Switzerland.
  • Hopfner KP; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Lyons PA; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
  • Boor P; Gene Center, Ludwig Maximilians University, Munich, Germany.
  • Rösen-Wolff A; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Teichmann LL; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Heeringa P; Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Kurts C; Department of Pediatrics, Universitätsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany.
  • Garbi N; Medical Clinic and Polyclinic III, University Hospital Bonn, Bonn, Germany.
J Exp Med ; 219(10)2022 10 03.
Article em En | MEDLINE | ID: mdl-35997679
ABSTRACT
Autoimmune vasculitis is a group of life-threatening diseases, whose underlying pathogenic mechanisms are incompletely understood, hampering development of targeted therapies. Here, we demonstrate that patients suffering from anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) showed increased levels of cGAMP and enhanced IFN-I signature. To identify disease mechanisms and potential therapeutic targets, we developed a mouse model for pulmonary AAV that mimics severe disease in patients. Immunogenic DNA accumulated during disease onset, triggering cGAS/STING/IRF3-dependent IFN-I release that promoted endothelial damage, pulmonary hemorrhages, and lung dysfunction. Macrophage subsets played dichotomic roles in disease. While recruited monocyte-derived macrophages were major disease drivers by producing most IFN-ß, resident alveolar macrophages contributed to tissue homeostasis by clearing red blood cells and limiting infiltration of IFN-ß-producing macrophages. Moreover, pharmacological inhibition of STING, IFNAR-I, or its downstream JAK/STAT signaling reduced disease severity and accelerated recovery. Our study unveils the importance of STING/IFN-I axis in promoting pulmonary AAV progression and identifies cellular and molecular targets to ameliorate disease outcomes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite / Ácidos Nucleicos / Interferon Tipo I Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasculite / Ácidos Nucleicos / Interferon Tipo I Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha